- Home
- OMAB vs PTCT Comparison
OMAB vs PTCT Comparison
Compare OMAB & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMAB
- PTCT
- Stock Information
- Founded
- OMAB 1998
- PTCT 1998
- Country
- OMAB Mexico
- PTCT United States
- Employees
- OMAB N/A
- PTCT N/A
- Industry
- OMAB Aerospace
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- OMAB Consumer Discretionary
- PTCT Health Care
- Exchange
- OMAB Nasdaq
- PTCT Nasdaq
- Market Cap
- OMAB 4.8B
- PTCT 3.9B
- IPO Year
- OMAB 2006
- PTCT 2013
- Fundamental
- Price
- OMAB $109.58
- PTCT $48.69
- Analyst Decision
- OMAB Buy
- PTCT Buy
- Analyst Count
- OMAB 4
- PTCT 14
- Target Price
- OMAB $102.50
- PTCT $63.57
- AVG Volume (30 Days)
- OMAB 66.2K
- PTCT 1.1M
- Earning Date
- OMAB 07-25-2025
- PTCT 08-07-2025
- Dividend Yield
- OMAB 3.67%
- PTCT N/A
- EPS Growth
- OMAB 2.49
- PTCT N/A
- EPS
- OMAB 0.65
- PTCT 7.51
- Revenue
- OMAB $728,352,552.00
- PTCT $1,772,758,000.00
- Revenue This Year
- OMAB $6.46
- PTCT $121.50
- Revenue Next Year
- OMAB $12.84
- PTCT N/A
- P/E Ratio
- OMAB $20.60
- PTCT $6.53
- Revenue Growth
- OMAB N/A
- PTCT 91.12
- 52 Week Low
- OMAB $59.08
- PTCT $29.02
- 52 Week High
- OMAB $108.93
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- OMAB 72.19
- PTCT 46.20
- Support Level
- OMAB $101.48
- PTCT $48.01
- Resistance Level
- OMAB $104.19
- PTCT $50.57
- Average True Range (ATR)
- OMAB 2.31
- PTCT 1.55
- MACD
- OMAB 0.32
- PTCT -0.34
- Stochastic Oscillator
- OMAB 100.00
- PTCT 15.32
About OMAB Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
Grupo Aeroportuario del Centro Norte SAB de CV operates airports in the central region of Mexico. The airport is in Monterrey, which serves nearly half of the company's total passengers. In addition, the company manages two hotels and one industrial park. Its reportable segments include its airports, the Terminal 2 NH Collection Hotel, the Hilton Garden Inn Hotel and the OMA-VYNMSA Industrial Park, individually, and information about its holding company and other companies is combined in the Others.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.